nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulpiride—DRD3—Parkinson's disease	0.506	0.591	CbGaD
Sulpiride—DRD2—Parkinson's disease	0.35	0.409	CbGaD
Sulpiride—DRD3—telencephalic ventricle—Parkinson's disease	0.00827	0.173	CbGeAlD
Sulpiride—DRD2—telencephalic ventricle—Parkinson's disease	0.0035	0.0732	CbGeAlD
Sulpiride—DRD2—nerve—Parkinson's disease	0.00221	0.0461	CbGeAlD
Sulpiride—Alizapride—DRD2—Parkinson's disease	0.00185	0.191	CrCbGaD
Sulpiride—CA12—forebrain—Parkinson's disease	0.00168	0.0352	CbGeAlD
Sulpiride—DRD2—hindbrain—Parkinson's disease	0.00165	0.0346	CbGeAlD
Sulpiride—CA2—hindbrain—Parkinson's disease	0.00156	0.0327	CbGeAlD
Sulpiride—CA6—head—Parkinson's disease	0.00144	0.0301	CbGeAlD
Sulpiride—Amisulpride—HTR7—Parkinson's disease	0.00133	0.138	CrCbGaD
Sulpiride—Remoxipride—DRD3—Parkinson's disease	0.00131	0.135	CrCbGaD
Sulpiride—Amisulpride—DRD3—Parkinson's disease	0.00125	0.129	CrCbGaD
Sulpiride—DRD3—head—Parkinson's disease	0.00124	0.0259	CbGeAlD
Sulpiride—DRD3—nervous system—Parkinson's disease	0.00117	0.0245	CbGeAlD
Sulpiride—CA9—cerebellum—Parkinson's disease	0.00116	0.0243	CbGeAlD
Sulpiride—DRD3—central nervous system—Parkinson's disease	0.00113	0.0236	CbGeAlD
Sulpiride—CA2—embryo—Parkinson's disease	0.000978	0.0205	CbGeAlD
Sulpiride—CA12—head—Parkinson's disease	0.000964	0.0202	CbGeAlD
Sulpiride—DRD2—brainstem—Parkinson's disease	0.000947	0.0198	CbGeAlD
Sulpiride—CA12—nervous system—Parkinson's disease	0.000914	0.0191	CbGeAlD
Sulpiride—DRD2—forebrain—Parkinson's disease	0.000914	0.0191	CbGeAlD
Sulpiride—Remoxipride—DRD2—Parkinson's disease	0.000903	0.0934	CrCbGaD
Sulpiride—DRD3—brain—Parkinson's disease	0.000896	0.0187	CbGeAlD
Sulpiride—CA2—brainstem—Parkinson's disease	0.000896	0.0187	CbGeAlD
Sulpiride—CA12—central nervous system—Parkinson's disease	0.00088	0.0184	CbGeAlD
Sulpiride—Amisulpride—DRD2—Parkinson's disease	0.000866	0.0895	CrCbGaD
Sulpiride—CA2—forebrain—Parkinson's disease	0.000865	0.0181	CbGeAlD
Sulpiride—BCHE—brainstem—Parkinson's disease	0.000859	0.018	CbGeAlD
Sulpiride—BCHE—forebrain—Parkinson's disease	0.000829	0.0173	CbGeAlD
Sulpiride—CA2—cardiovascular system—Parkinson's disease	0.000731	0.0153	CbGeAlD
Sulpiride—BCHE—cardiovascular system—Parkinson's disease	0.000701	0.0147	CbGeAlD
Sulpiride—CA12—brain—Parkinson's disease	0.000699	0.0146	CbGeAlD
Sulpiride—Remoxipride—HTR2A—Parkinson's disease	0.000698	0.0722	CrCbGaD
Sulpiride—Amisulpride—HTR2A—Parkinson's disease	0.000669	0.0692	CrCbGaD
Sulpiride—Remoxipride—CYP2D6—Parkinson's disease	0.000638	0.066	CrCbGaD
Sulpiride—CA2—medulla oblongata—Parkinson's disease	0.000625	0.0131	CbGeAlD
Sulpiride—DRD2—midbrain—Parkinson's disease	0.000603	0.0126	CbGeAlD
Sulpiride—BCHE—medulla oblongata—Parkinson's disease	0.000599	0.0125	CbGeAlD
Sulpiride—CA2—midbrain—Parkinson's disease	0.000571	0.0119	CbGeAlD
Sulpiride—CA2—spinal cord—Parkinson's disease	0.000557	0.0117	CbGeAlD
Sulpiride—BCHE—midbrain—Parkinson's disease	0.000547	0.0114	CbGeAlD
Sulpiride—BCHE—spinal cord—Parkinson's disease	0.000534	0.0112	CbGeAlD
Sulpiride—DRD2—head—Parkinson's disease	0.000523	0.0109	CbGeAlD
Sulpiride—DRD2—nervous system—Parkinson's disease	0.000496	0.0104	CbGeAlD
Sulpiride—CA2—head—Parkinson's disease	0.000495	0.0104	CbGeAlD
Sulpiride—DRD2—central nervous system—Parkinson's disease	0.000478	0.00999	CbGeAlD
Sulpiride—BCHE—head—Parkinson's disease	0.000475	0.00993	CbGeAlD
Sulpiride—CA2—nervous system—Parkinson's disease	0.000469	0.00982	CbGeAlD
Sulpiride—DRD2—cerebellum—Parkinson's disease	0.000467	0.00976	CbGeAlD
Sulpiride—CA2—central nervous system—Parkinson's disease	0.000452	0.00946	CbGeAlD
Sulpiride—BCHE—nervous system—Parkinson's disease	0.00045	0.00941	CbGeAlD
Sulpiride—CA2—cerebellum—Parkinson's disease	0.000442	0.00924	CbGeAlD
Sulpiride—BCHE—central nervous system—Parkinson's disease	0.000433	0.00906	CbGeAlD
Sulpiride—BCHE—cerebellum—Parkinson's disease	0.000423	0.00886	CbGeAlD
Sulpiride—DRD2—brain—Parkinson's disease	0.000379	0.00793	CbGeAlD
Sulpiride—CA2—brain—Parkinson's disease	0.000359	0.00751	CbGeAlD
Sulpiride—BCHE—brain—Parkinson's disease	0.000344	0.00719	CbGeAlD
Sulpiride—Glyburide—ABCB1—Parkinson's disease	0.000162	0.0167	CrCbGaD
Sulpiride—CA6—Metabolism—TH—Parkinson's disease	8.93e-05	0.00104	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	8.92e-05	0.00104	CbGpPWpGaD
Sulpiride—CA9—Metabolism—DDC—Parkinson's disease	8.92e-05	0.00104	CbGpPWpGaD
Sulpiride—CA2—Metabolism—MAOB—Parkinson's disease	8.91e-05	0.00104	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—DRD1—Parkinson's disease	8.88e-05	0.00103	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—GRK5—Parkinson's disease	8.85e-05	0.00103	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—GRM4—Parkinson's disease	8.74e-05	0.00102	CbGpPWpGaD
Sulpiride—CA12—Metabolism—CYP2D6—Parkinson's disease	8.66e-05	0.00101	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	8.64e-05	0.00101	CbGpPWpGaD
Sulpiride—CA6—Metabolism—CYCS—Parkinson's disease	8.57e-05	0.000997	CbGpPWpGaD
Sulpiride—CA12—Metabolism—CTGF—Parkinson's disease	8.5e-05	0.000989	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—OMD—Parkinson's disease	8.45e-05	0.000983	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—TALDO1—Parkinson's disease	8.45e-05	0.000983	CbGpPWpGaD
Sulpiride—CA9—Metabolism—GSTA4—Parkinson's disease	8.43e-05	0.00098	CbGpPWpGaD
Sulpiride—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	8.35e-05	0.000972	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—VPS35—Parkinson's disease	8.32e-05	0.000968	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—PENK—Parkinson's disease	8.28e-05	0.000964	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	8.18e-05	0.000952	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—PPP1R1B—Parkinson's disease	8.17e-05	0.000951	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—ADORA2A—Parkinson's disease	8.11e-05	0.000944	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—NDUFB11—Parkinson's disease	8.01e-05	0.000932	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—RPL14—Parkinson's disease	8e-05	0.000931	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—RPL23A—Parkinson's disease	8e-05	0.000931	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—GRM4—Parkinson's disease	7.94e-05	0.000923	CbGpPWpGaD
Sulpiride—CA12—Metabolism—CYP2E1—Parkinson's disease	7.92e-05	0.000922	CbGpPWpGaD
Sulpiride—CA12—Metabolism—NQO1—Parkinson's disease	7.83e-05	0.000911	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	7.82e-05	0.000909	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—HTR7—Parkinson's disease	7.78e-05	0.000905	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—DRD2—Parkinson's disease	7.78e-05	0.000905	CbGpPWpGaD
Sulpiride—CA9—Cellular responses to stress—MAPK8—Parkinson's disease	7.72e-05	0.000899	CbGpPWpGaD
Sulpiride—CA12—Metabolism—TH—Parkinson's disease	7.72e-05	0.000898	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GCH1—Parkinson's disease	7.64e-05	0.000889	CbGpPWpGaD
Sulpiride—CA6—Metabolism—COMT—Parkinson's disease	7.59e-05	0.000883	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PLA2G6—Parkinson's disease	7.59e-05	0.000883	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—PDYN—Parkinson's disease	7.58e-05	0.000882	CbGpPWpGaD
Sulpiride—CA6—Metabolism—GSTP1—Parkinson's disease	7.55e-05	0.000879	CbGpPWpGaD
Sulpiride—CA6—Metabolism—MAOA—Parkinson's disease	7.54e-05	0.000877	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—PENK—Parkinson's disease	7.52e-05	0.000875	CbGpPWpGaD
Sulpiride—CA9—Metabolism—MAOB—Parkinson's disease	7.51e-05	0.000874	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—RPS8—Parkinson's disease	7.46e-05	0.000868	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—GRK5—Parkinson's disease	7.45e-05	0.000867	CbGpPWpGaD
Sulpiride—CA6—Metabolism—HMOX1—Parkinson's disease	7.45e-05	0.000867	CbGpPWpGaD
Sulpiride—CA12—Metabolism—CYCS—Parkinson's disease	7.41e-05	0.000862	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	7.15e-05	0.000832	CbGpPWpGaD
Sulpiride—CA6—Metabolism—ABCB1—Parkinson's disease	7.15e-05	0.000832	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—GRM5—Parkinson's disease	7.04e-05	0.00082	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—HTR1A—Parkinson's disease	7.04e-05	0.000819	CbGpPWpGaD
Sulpiride—CA6—Metabolism—GSTM1—Parkinson's disease	6.94e-05	0.000808	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—TAC1—Parkinson's disease	6.93e-05	0.000806	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—GPR37—Parkinson's disease	6.9e-05	0.000802	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—DGKQ—Parkinson's disease	6.9e-05	0.000802	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	6.89e-05	0.000802	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—PDYN—Parkinson's disease	6.88e-05	0.000801	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—FBP1—Parkinson's disease	6.81e-05	0.000792	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—DBH—Parkinson's disease	6.81e-05	0.000792	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GBA—Parkinson's disease	6.81e-05	0.000792	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—DRD1—Parkinson's disease	6.8e-05	0.000791	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—GRK5—Parkinson's disease	6.77e-05	0.000788	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—GRM4—Parkinson's disease	6.69e-05	0.000778	CbGpPWpGaD
Sulpiride—CA6—Metabolism—GPX1—Parkinson's disease	6.65e-05	0.000773	CbGpPWpGaD
Sulpiride—CA2—Metabolism—CYP2D6—Parkinson's disease	6.62e-05	0.000771	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—DRD3—Parkinson's disease	6.58e-05	0.000766	CbGpPWpGaD
Sulpiride—CA12—Metabolism—COMT—Parkinson's disease	6.56e-05	0.000764	CbGpPWpGaD
Sulpiride—CA12—Metabolism—GSTP1—Parkinson's disease	6.53e-05	0.00076	CbGpPWpGaD
Sulpiride—CA12—Metabolism—MAOA—Parkinson's disease	6.52e-05	0.000758	CbGpPWpGaD
Sulpiride—CA2—Metabolism—CTGF—Parkinson's disease	6.5e-05	0.000756	CbGpPWpGaD
Sulpiride—CA12—Metabolism—HMOX1—Parkinson's disease	6.44e-05	0.00075	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—GRM5—Parkinson's disease	6.4e-05	0.000744	CbGpPWpGaD
Sulpiride—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	6.39e-05	0.000743	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—VPS35—Parkinson's disease	6.37e-05	0.000741	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—PENK—Parkinson's disease	6.34e-05	0.000738	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PPP1R1B—Parkinson's disease	6.31e-05	0.000734	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	6.26e-05	0.000728	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—EDN1—Parkinson's disease	6.23e-05	0.000725	CbGpPWpGaD
Sulpiride—CA12—Metabolism—ABCB1—Parkinson's disease	6.18e-05	0.00072	CbGpPWpGaD
Sulpiride—CA6—Metabolism—MTHFR—Parkinson's disease	6.14e-05	0.000714	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—GRM4—Parkinson's disease	6.07e-05	0.000706	CbGpPWpGaD
Sulpiride—CA2—Metabolism—CYP2E1—Parkinson's disease	6.06e-05	0.000705	CbGpPWpGaD
Sulpiride—CA12—Metabolism—GSTM1—Parkinson's disease	6e-05	0.000699	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—ADORA2A—Parkinson's disease	5.99e-05	0.000697	CbGpPWpGaD
Sulpiride—CA2—Metabolism—NQO1—Parkinson's disease	5.99e-05	0.000697	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—HTR7—Parkinson's disease	5.95e-05	0.000693	CbGpPWpGaD
Sulpiride—CA2—Metabolism—TH—Parkinson's disease	5.9e-05	0.000687	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—PDYN—Parkinson's disease	5.8e-05	0.000675	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—PENK—Parkinson's disease	5.76e-05	0.00067	CbGpPWpGaD
Sulpiride—CA12—Metabolism—GPX1—Parkinson's disease	5.75e-05	0.000669	CbGpPWpGaD
Sulpiride—CA6—Metabolism—APOE—Parkinson's disease	5.71e-05	0.000665	CbGpPWpGaD
Sulpiride—CA2—Metabolism—CYCS—Parkinson's disease	5.67e-05	0.000659	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CYP2D6—Parkinson's disease	5.58e-05	0.000649	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—MAPK8—Parkinson's disease	5.54e-05	0.000645	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—RIT2—Parkinson's disease	5.51e-05	0.000641	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CTGF—Parkinson's disease	5.48e-05	0.000637	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	5.47e-05	0.000637	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—HTR2A—Parkinson's disease	5.45e-05	0.000634	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—ADORA2A—Parkinson's disease	5.44e-05	0.000633	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—GRM5—Parkinson's disease	5.39e-05	0.000627	CbGpPWpGaD
Sulpiride—CA12—Metabolism—MTHFR—Parkinson's disease	5.31e-05	0.000617	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GPR37—Parkinson's disease	5.28e-05	0.000614	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—DGKQ—Parkinson's disease	5.28e-05	0.000614	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—PDYN—Parkinson's disease	5.26e-05	0.000613	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—GRK5—Parkinson's disease	5.23e-05	0.000608	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—HTR1A—Parkinson's disease	5.2e-05	0.000605	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—TAC1—Parkinson's disease	5.12e-05	0.000595	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CYP2E1—Parkinson's disease	5.11e-05	0.000594	CbGpPWpGaD
Sulpiride—CA9—Metabolism—NQO1—Parkinson's disease	5.05e-05	0.000587	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—DRD1—Parkinson's disease	5.02e-05	0.000584	CbGpPWpGaD
Sulpiride—CA2—Metabolism—COMT—Parkinson's disease	5.02e-05	0.000584	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—DDC—Parkinson's disease	5e-05	0.000581	CbGpPWpGaD
Sulpiride—CA2—Metabolism—GSTP1—Parkinson's disease	5e-05	0.000581	CbGpPWpGaD
Sulpiride—CA2—Metabolism—MAOA—Parkinson's disease	4.98e-05	0.00058	CbGpPWpGaD
Sulpiride—CA9—Metabolism—TH—Parkinson's disease	4.97e-05	0.000579	CbGpPWpGaD
Sulpiride—CA12—Metabolism—APOE—Parkinson's disease	4.94e-05	0.000575	CbGpPWpGaD
Sulpiride—CA9—Cellular responses to stress—IL6—Parkinson's disease	4.93e-05	0.000574	CbGpPWpGaD
Sulpiride—CA2—Metabolism—HMOX1—Parkinson's disease	4.93e-05	0.000573	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—GRM5—Parkinson's disease	4.89e-05	0.000569	CbGpPWpGaD
Sulpiride—CA6—Metabolism—INS—Parkinson's disease	4.88e-05	0.000568	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PPP1R1B—Parkinson's disease	4.83e-05	0.000562	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CYCS—Parkinson's disease	4.78e-05	0.000556	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—EDN1—Parkinson's disease	4.77e-05	0.000554	CbGpPWpGaD
Sulpiride—CA2—Metabolism—ABCB1—Parkinson's disease	4.73e-05	0.00055	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—HTR1A—Parkinson's disease	4.72e-05	0.000549	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GSTA4—Parkinson's disease	4.72e-05	0.000549	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—GRM4—Parkinson's disease	4.69e-05	0.000545	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4.66e-05	0.000542	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—TAC1—Parkinson's disease	4.65e-05	0.000541	CbGpPWpGaD
Sulpiride—CA2—Metabolism—GSTM1—Parkinson's disease	4.59e-05	0.000534	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—ADORA2A—Parkinson's disease	4.58e-05	0.000533	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—DRD1—Parkinson's disease	4.56e-05	0.00053	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—ADRBK1—Parkinson's disease	4.54e-05	0.000528	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—IGF2—Parkinson's disease	4.45e-05	0.000518	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—MAG—Parkinson's disease	4.44e-05	0.000517	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PENK—Parkinson's disease	4.44e-05	0.000517	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—DRD2—Parkinson's disease	4.4e-05	0.000511	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—HTR7—Parkinson's disease	4.4e-05	0.000511	CbGpPWpGaD
Sulpiride—CA2—Metabolism—GPX1—Parkinson's disease	4.4e-05	0.000511	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PLA2G6—Parkinson's disease	4.25e-05	0.000494	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—MAPK8—Parkinson's disease	4.24e-05	0.000493	CbGpPWpGaD
Sulpiride—CA9—Metabolism—COMT—Parkinson's disease	4.23e-05	0.000492	CbGpPWpGaD
Sulpiride—CA12—Metabolism—INS—Parkinson's disease	4.22e-05	0.000491	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—RIT2—Parkinson's disease	4.22e-05	0.000491	CbGpPWpGaD
Sulpiride—CA9—Metabolism—GSTP1—Parkinson's disease	4.21e-05	0.00049	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—MAOB—Parkinson's disease	4.21e-05	0.000489	CbGpPWpGaD
Sulpiride—CA9—Metabolism—MAOA—Parkinson's disease	4.2e-05	0.000489	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—HTR2A—Parkinson's disease	4.17e-05	0.000485	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—ADORA2A—Parkinson's disease	4.16e-05	0.000484	CbGpPWpGaD
Sulpiride—CA9—Metabolism—HMOX1—Parkinson's disease	4.15e-05	0.000483	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—ADRBK1—Parkinson's disease	4.12e-05	0.00048	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PDYN—Parkinson's disease	4.06e-05	0.000473	CbGpPWpGaD
Sulpiride—CA2—Metabolism—MTHFR—Parkinson's disease	4.06e-05	0.000472	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	4e-05	0.000466	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GRK5—Parkinson's disease	4e-05	0.000465	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—HTR7—Parkinson's disease	3.99e-05	0.000464	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—DRD2—Parkinson's disease	3.99e-05	0.000464	CbGpPWpGaD
Sulpiride—CA9—Metabolism—ABCB1—Parkinson's disease	3.99e-05	0.000464	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—HTR1A—Parkinson's disease	3.98e-05	0.000463	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—TAC1—Parkinson's disease	3.92e-05	0.000456	CbGpPWpGaD
Sulpiride—CA9—Metabolism—GSTM1—Parkinson's disease	3.87e-05	0.00045	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—DRD1—Parkinson's disease	3.84e-05	0.000447	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—GFAP—Parkinson's disease	3.82e-05	0.000445	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—GRM5—Parkinson's disease	3.78e-05	0.00044	CbGpPWpGaD
Sulpiride—CA2—Metabolism—APOE—Parkinson's disease	3.78e-05	0.000439	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—DRD3—Parkinson's disease	3.72e-05	0.000433	CbGpPWpGaD
Sulpiride—CA9—Metabolism—GPX1—Parkinson's disease	3.71e-05	0.000431	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—HTR1A—Parkinson's disease	3.61e-05	0.00042	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GRM4—Parkinson's disease	3.59e-05	0.000417	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—TAC1—Parkinson's disease	3.56e-05	0.000414	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—IL6—Parkinson's disease	3.54e-05	0.000412	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—EDN1—Parkinson's disease	3.52e-05	0.000409	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—DRD1—Parkinson's disease	3.49e-05	0.000406	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—ADRBK1—Parkinson's disease	3.47e-05	0.000404	CbGpPWpGaD
Sulpiride—CA9—Metabolism—MTHFR—Parkinson's disease	3.42e-05	0.000398	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PENK—Parkinson's disease	3.4e-05	0.000396	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—MAG—Parkinson's disease	3.4e-05	0.000396	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—DRD3—Parkinson's disease	3.38e-05	0.000393	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—HTR7—Parkinson's disease	3.36e-05	0.000391	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—FGF20—Parkinson's disease	3.31e-05	0.000385	CbGpPWpGaD
Sulpiride—CA2—Metabolism—INS—Parkinson's disease	3.23e-05	0.000375	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ADORA2A—Parkinson's disease	3.21e-05	0.000374	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—EDN1—Parkinson's disease	3.2e-05	0.000372	CbGpPWpGaD
Sulpiride—CA9—Metabolism—APOE—Parkinson's disease	3.18e-05	0.00037	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—ADRBK1—Parkinson's disease	3.15e-05	0.000367	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CYP2D6—Parkinson's disease	3.13e-05	0.000364	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PDYN—Parkinson's disease	3.11e-05	0.000362	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—HTR2A—Parkinson's disease	3.08e-05	0.000358	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CTGF—Parkinson's disease	3.07e-05	0.000357	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—HTR7—Parkinson's disease	3.05e-05	0.000355	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—INSR—Parkinson's disease	2.97e-05	0.000345	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—INS—Parkinson's disease	2.95e-05	0.000344	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GFAP—Parkinson's disease	2.92e-05	0.00034	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GRM5—Parkinson's disease	2.89e-05	0.000336	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CYP2E1—Parkinson's disease	2.86e-05	0.000333	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—NQO1—Parkinson's disease	2.83e-05	0.000329	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—FGB—Parkinson's disease	2.8e-05	0.000326	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—HTR2A—Parkinson's disease	2.8e-05	0.000325	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—HTR1A—Parkinson's disease	2.79e-05	0.000324	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—TH—Parkinson's disease	2.79e-05	0.000324	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TAC1—Parkinson's disease	2.75e-05	0.000319	CbGpPWpGaD
Sulpiride—CA9—Metabolism—INS—Parkinson's disease	2.72e-05	0.000316	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—IL6—Parkinson's disease	2.71e-05	0.000315	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—EDN1—Parkinson's disease	2.69e-05	0.000313	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—DRD1—Parkinson's disease	2.69e-05	0.000313	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CYCS—Parkinson's disease	2.67e-05	0.000311	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—FGF20—Parkinson's disease	2.54e-05	0.000295	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ADORA2A—Parkinson's disease	2.46e-05	0.000286	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—EDN1—Parkinson's disease	2.45e-05	0.000285	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ADRBK1—Parkinson's disease	2.43e-05	0.000283	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—COMT—Parkinson's disease	2.37e-05	0.000276	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—DRD2—Parkinson's disease	2.36e-05	0.000274	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—HTR7—Parkinson's disease	2.36e-05	0.000274	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GSTP1—Parkinson's disease	2.36e-05	0.000274	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—HTR2A—Parkinson's disease	2.36e-05	0.000274	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—MAOA—Parkinson's disease	2.35e-05	0.000274	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—HMOX1—Parkinson's disease	2.33e-05	0.000271	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—INSR—Parkinson's disease	2.27e-05	0.000264	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—ABCB1—Parkinson's disease	2.23e-05	0.00026	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GSTM1—Parkinson's disease	2.17e-05	0.000252	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—FGB—Parkinson's disease	2.14e-05	0.000249	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	2.14e-05	0.000249	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	2.13e-05	0.000248	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TAC1—Parkinson's disease	2.1e-05	0.000244	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GPX1—Parkinson's disease	2.07e-05	0.000241	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—DRD1—Parkinson's disease	2.06e-05	0.00024	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—DRD3—Parkinson's disease	2e-05	0.000232	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IGF2—Parkinson's disease	1.98e-05	0.00023	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—MTHFR—Parkinson's disease	1.91e-05	0.000223	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IGF1R—Parkinson's disease	1.91e-05	0.000222	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—EDN1—Parkinson's disease	1.89e-05	0.00022	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	1.86e-05	0.000217	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—HTR7—Parkinson's disease	1.8e-05	0.00021	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—APOE—Parkinson's disease	1.78e-05	0.000207	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—NGF—Parkinson's disease	1.73e-05	0.000202	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—HTR2A—Parkinson's disease	1.65e-05	0.000192	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—APOE—Parkinson's disease	1.54e-05	0.000179	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—INS—Parkinson's disease	1.52e-05	0.000177	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IGF2—Parkinson's disease	1.51e-05	0.000176	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	1.46e-05	0.00017	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—EDN1—Parkinson's disease	1.44e-05	0.000168	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—NGF—Parkinson's disease	1.33e-05	0.000154	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—INS—Parkinson's disease	1.31e-05	0.000153	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	1.26e-05	0.000147	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—APOE—Parkinson's disease	1.17e-05	0.000137	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—INS—Parkinson's disease	1e-05	0.000117	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CASP3—Parkinson's disease	9.77e-06	0.000114	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—IL6—Parkinson's disease	9.7e-06	0.000113	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—MAPK8—Parkinson's disease	8.98e-06	0.000104	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CASP3—Parkinson's disease	7.47e-06	8.69e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—IL6—Parkinson's disease	7.42e-06	8.64e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	6.87e-06	7.99e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IL6—Parkinson's disease	5.73e-06	6.67e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IL6—Parkinson's disease	4.39e-06	5.1e-05	CbGpPWpGaD
